Atlas Venture Life Science Advisors as of June 30, 2025
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 11 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 32.3 | $214M | 4.9M | 43.64 | |
| Disc Medicine Common Stock (IRON) | 19.1 | $126M | 2.4M | 52.96 | |
| Dyne Therapeutics Common Stock (DYN) | 13.1 | $87M | 9.1M | 9.52 | |
| Sionna Therapeutics Common Stock (SION) | 9.7 | $64M | 3.7M | 17.35 | |
| Third Harmonic Bio Common Stock (THRD) | 8.5 | $57M | 10M | 5.43 | |
| Vigil Neuroscience Common Stock (VIGL) | 7.0 | $46M | 5.8M | 7.95 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 6.3 | $42M | 6.4M | 6.50 | |
| Korro Bio Common Stock (KRRO) | 2.1 | $14M | 1.1M | 12.49 | |
| Ikena Oncology Common Stock (IKNA) | 1.0 | $6.7M | 5.0M | 1.34 | |
| Q32 Bio Common Stock (QTTB) | 0.5 | $3.1M | 2.1M | 1.49 | |
| Generation Bio Common Stock | 0.4 | $2.7M | 8.3M | 0.32 |
